Abbott Laboratories (ABT) News
Track canonical SquawkNews coverage tagged to ABT, Abbott Laboratories. This hub brings together deduplicated headlines about united states, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 65 indexed stories across 25 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health
ABBOTT PARK, Ill. and NEW YORK, Sept. 23, 2026 // -- Abbott (NYSE:ABT) and Berry Street today announced an exclusive partnership to help people take a more proactive approach to nutrition and long-term health. The partne
NEWS | Sep 23, 2026, 11:00 AM UTC
L
ABT - Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health
ABT - Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health
NEWS | Sep 23, 2026, 11:00 AM UTC
M
Grail shares surge after FDA staff see no major test concerns
US FDA staff reviewers said they did not raise major concerns about the accuracy and safety of Grail’s multi-cancer blood test. Grail’s shares surged 35% on Monday.
EQUITY | Sep 21, 2026, 04:41 PM UTC
H
Top News Today: Stocks Fall; AI Slowdown Fears Weigh on Tech; Oil Rises
MARKET WRAPSSTOCKS: Stocks fell amid fears that artificial-intelligence companies will slow development of the emerging technology.TREASURYS: Treasury yields fell but the yield on the 10-year note crossed the 5% level in
COMMODITIES | Sep 14, 2026, 08:39 PM UTC
M
Abbott agrees to $385 million settlement in baby formula case
Abbott Laboratories agreed to pay $385 million to settle allegations tied to its management of a baby formula facility, the U.S. Justice Department said.
REGULATION | Sep 14, 2026, 05:46 PM UTC
M
Abbott to pay about $385 million to resolve baby formula claims
Abbott Laboratories agreed to pay about $385 million to resolve U.S. allegations that it sold contaminated baby formula.
EQUITY | Sep 14, 2026, 04:31 PM UTC
H
Abbott agrees to DOJ settlement over 2022 infant formula recall
REGULATION | Sep 14, 2026, 03:57 PM UTC
L
Abbott (ABT) price target held at $135 by TD Cowen
Benzinga via TradingView reports TD Cowen maintained its price target for Abbott at $135.00 per share.
EQUITY | Sep 08, 2026, 02:07 PM UTC
M
Abbott gets FDA approval for TactiFlex Duo ablation catheter
Abbott Laboratories said it received FDA approval for its TactiFlex Duo ablation catheter to treat people with abnormal heart rhythms.
REGULATION | Sep 08, 2026, 01:10 PM UTC
M
Abbott wins FDA approval for TactiFlex Duo ablation catheter
Abbott announced it received U.S. FDA approval for the TactiFlex Duo Ablation Catheter, Sensor Enabled, to treat challenging atrial fibrillation (AFib) cases.
REGULATION | Sep 08, 2026, 12:03 PM UTC
L
Abbott CEO and Chairman sells shares worth over $46M
Abbott CEO and Chairman sold shares worth over $46M, according to TradingView News.
EQUITY | Aug 27, 2026, 09:21 PM UTC
L
Abbott Amulet 360™ gets CE mark for atrial fibrillation stroke treatment
Abbott’s Next-Generation Amulet 360™ device received CE mark to treat people with atrial fibrillation at risk of stroke.
EQUITY | Aug 27, 2026, 01:22 PM UTC
L
Abbott Amulet 360™ gets CE Mark for atrial fibrillation stroke-risk treatment
Abbott’s next-generation Amulet 360™ device received CE Mark to treat people with atrial fibrillation at risk of stroke.
EQUITY | Aug 27, 2026, 01:01 PM UTC
M
FDA clears Abbott Libre Duo 10-day dual glucose/ketone monitor
The FDA clears Abbott’s Libre Duo 10-day dual glucose ketone monitor, described as the first in the US to track ketones continuously.
REGULATION | Aug 25, 2026, 06:27 PM UTC
L
TD Cowen raises Abbott price target to $135 from $115
TD Cowen raises its price target on Abbott Laboratories to $135 from $115, with no additional catalyst supplied in the alert.
EQUITY | Aug 21, 2026, 10:00 AM UTC
H
Abbott (ABT) to pay about $670M to resolve gill, nec claims
Abbott (ABT) said it will pay about $670M to resolve gill case and nec claims, with about 1,700 lawsuits still pending involving claims for 12,700 infants.
REGULATION | Aug 20, 2026, 08:15 PM UTC
L
Abbott reaches agreements to resolve portion of specialty-formula litigation
Abbott says it has reached agreements to resolve a portion of litigation involving its specialty formulas for preterm infants, with no terms disclosed in the alert.
REGULATION | Aug 20, 2026, 08:15 PM UTC
L
Abbott reaches agreements to resolve Gill case, 2,000 related claims
Abbott says it has reached agreements to resolve the Gill case and 2,000 related claims.
REGULATION | Aug 20, 2026, 08:15 PM UTC
L
Abbott reaches agreements on preterm infant formula litigation
Abbott says it has reached agreements to resolve a portion of litigation involving its Specialty formulas for preterm infants.
REGULATION | Aug 20, 2026, 08:15 PM UTC
L
Abbott (ABT) and NACHC launch nationwide Food for Health initiative
Abbott (ABT) and NACHC have launched a nationwide Food for Health initiative aimed at making nutritious food a core part of healthcare.
REGULATION | Aug 17, 2026, 05:45 PM UTC
L
Rep. Mike Kelly discloses sales of ABT, DIS and PEP
Rep. Mike Kelly (R-Penn.) disclosed spouse-reported July 17 sales of Abbott Laboratories, Walt Disney and PepsiCo shares, plus a $50,000 to $100,000 municipal bond purchase.
REGULATION | Aug 13, 2026, 09:45 PM UTC
L
ABT: Abbott Revives Blood Donation Campaign
Abbott and Big Ten revive 'We Give Blood' amid US blood supply crisis
EQUITY | Aug 12, 2026, 01:15 PM UTC
H
Abbott Partners With Google Health To Combine Glucose Insights From Abbott's Lingo Biowearable With Google's Expertise In AI To Make Persona
The collaboration is designed to bring metabolic health insights into people's daily routines through a seamless, AI-powered experience. Through the Google Health app, Lingo users will be able to view glucose trends alon
EQUITY | Aug 11, 2026, 01:09 PM UTC
M
Abbott and Google Launch Partnership
Abbott partners with Google for health insights
EQUITY | Aug 11, 2026, 01:01 PM UTC
L
BAX DXCM ENOV HSIC NUE OVV OZK TFII ABT AMZN ATRC BBNX BKR BSX CEG MCB NRG RXST SGHT TNDM VST PT changes @ UBS
BAX DXCM ENOV HSIC NUE OVV OZK TFII ABT AMZN ATRC BBNX BKR BSX CEG MCB NRG RXST SGHT TNDM VST PT changes @ UBS
EQUITY | Jul 28, 2026, 11:47 AM UTC
L
FRNM +10% in pre-mkt ABT following earlier PR: Freenome And Abbott Receive FDA Approval For The SimpleScreen CRC Blood-Based Screening Optio
FRNM +10% in pre-mkt ABT following earlier PR: Freenome And Abbott Receive FDA Approval For The SimpleScreen CRC Blood-Based Screening Option For Colorectal Cancer, With Freenome Earning $100M Milestone Payment Link To P
REGULATION | Jul 27, 2026, 01:04 PM UTC
H
Abbott Laboratories (ABT) Fell as Guidance and Litigation Concerns Overshadowed Growth
Abbott Laboratories (ABT) Fell as Guidance and Litigation Concerns Overshadowed Growth
EQUITY | Jul 27, 2026, 01:02 PM UTC
L
Freenome, Abbott announce FDA approval of SimpleScreen CRC
Freenome (FRNM) and...
EQUITY | Jul 27, 2026, 12:12 PM UTC
L
ABT Abbott Laboratories wins dismissal of shareholder lawsuit stemming from 2022 infant Formula recall, court ruling shows
ABT Abbott Laboratories wins dismissal of shareholder lawsuit stemming from 2022 infant Formula recall, court ruling shows
REGULATION | Jul 24, 2026, 07:59 PM UTC
L
BSX DXCM EW GEHC GMED MDT SYK ZBH readthroughs from ABT JNJ ISRG results @ RBC
BSX DXCM EW GEHC GMED MDT SYK ZBH readthroughs from ABT JNJ ISRG results @ RBC
EQUITY | Jul 21, 2026, 12:24 PM UTC
L
Outperformers vs S&P sector ETFs (% chg vs ETF) Consumer Discretionary (XLY) - F +2.55%, EBAY +2.51%, CMG +2.32%, ULTA +1.82%, ROST +1.59% C
Outperformers vs S&P sector ETFs (% chg vs ETF) Consumer Discretionary (XLY) - F +2.55%, EBAY +2.51%, CMG +2.32%, ULTA +1.82%, ROST +1.59% Consumer Staples (XLP) - CASY +4.30%, ADM +3.55%, BG +3.38%, MO +2.46%, PM +1.84%
RATES | Jul 17, 2026, 07:07 PM UTC
H
These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results
Abbott Laboratories (NYSE: ABT ) reported upbeat second-quarter results and raised its full-year adjusted earnings outlook on Thursday. Adjusted earnings came in at $1.31 per share, topping the analyst consensus estimate
EARNINGS | Jul 17, 2026, 01:38 PM UTC
H
ABT Abbott Labs got a round of price target increases after reporting a much improved quarter on Thursday. Management also raised its full-y
ABT Abbott Labs got a round of price target increases after reporting a much improved quarter on Thursday. Management also raised its full-year guidance for adjusted earnings, forecasting a range of $5.45 to $5.60 per sh
EARNINGS | Jul 17, 2026, 01:17 PM UTC
H
Why Is Intuitive Surgical Stock Sinking Friday?
Intuitive Surgical Inc. (NASDAQ: ISRG ) stock fell more than 11% in Friday premarket trading after the robotic surgery company reported second-quarter results that topped Wall Street estimates but reaffirmed its procedur
EARNINGS | Jul 17, 2026, 11:41 AM UTC
L
ABT Raise PT to $112 from $108 after a very good Q2 and raise @ Citi
ABT Raise PT to $112 from $108 after a very good Q2 and raise @ Citi
EQUITY | Jul 17, 2026, 10:59 AM UTC
H
What You Missed On Wall Street On Thursday
The major averages closed broadly lower amid a new wave of corporate earnings reports and renewed weakness in the semiconductor space. Earnings season has started off strong this week, as more than 87% of the 40 S&P 500
RATES | Jul 16, 2026, 08:25 PM UTC
H
Abbott Brushes Off Procedure Volume Concerns, Lifts Outlook
Abbott Laboratories (NYSE: ABT ) stock rose Thursday after the healthcare company reported second-quarter 2026 results that beat Wall Street estimates on both earnings and revenue and raised its full-year adjusted earnin
EARNINGS | Jul 16, 2026, 05:10 PM UTC
H
Midday Fly By: UnitedHealth, United Airlines, GE Aersopace report Q2 beats
The Dow Jones Industrial Average was higher near noon while the S&P 500 and Nasdaq were lower as investors digest a new wave of corporate earnings reports and renewed weakness in the semiconductor space. Markets continue
MACRO | Jul 16, 2026, 04:10 PM UTC
H
Abbott Stock's Best Day Ever: +13.6% On Earnings Beat, Guidance Raise
Nothing in Abbott Laboratories (NYSE: ABT ) ‘s trading history since 1968 resembles Thursday morning. A three-cent earnings beat and a narrow guidance raise unlocked the largest single-day advance the stock has ever reco
EARNINGS | Jul 16, 2026, 02:45 PM UTC
H
Abbott Laboratories Reports Q2 2026 Results: Full Earnings Call Transcript
Abbott Laboratories (NYSE: ABT ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. APIs provide real-time access to earnings call transcripts and finan
EARNINGS | Jul 16, 2026, 02:27 PM UTC
H
Abbott Laboratories, AtaiBeckley, ManpowerGroup And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Nasdaq Composite falling around 150 points on Thursday. Shares of Abbott Laboratories (NYSE: ABT ) rose sharply after the company reported better-than-expected second-quarter financial re
EARNINGS | Jul 16, 2026, 02:11 PM UTC
L
Unusually active option classes on open July 16th
Unusually active option classes on open July 16th
EQUITY | Jul 16, 2026, 01:42 PM UTC
L
ABT Abbott Labs climbs to session-high 11%, up most since 2020 (more)
ABT Abbott Labs climbs to session-high 11%, up most since 2020 (more)
EQUITY | Jul 16, 2026, 01:40 PM UTC
H
ABT shares up over 10% following its earnings and guidance
ABT shares up over 10% following its earnings and guidance
EARNINGS | Jul 16, 2026, 01:35 PM UTC
L
ABT premarket highs +6% after results
ABT premarket highs +6% after results
EQUITY | Jul 16, 2026, 01:15 PM UTC
H
among early movers from the earnings calendar this morning gainers MAN +9.6%, UNH +5.9%, ABT +2.2%, STT +1.8%, CFG +1.1%, PLD +1.0% decliner
among early movers from the earnings calendar this morning gainers MAN +9.6%, UNH +5.9%, ABT +2.2%, STT +1.8%, CFG +1.1%, PLD +1.0% decliners IIIN -3.5%, GE -3.0%, USB -0.9% among early movers from the earnings calendar
EARNINGS | Jul 16, 2026, 11:57 AM UTC
L
ABT +3% premarket after 2026 profit forecast raise
ABT +3% premarket after 2026 profit forecast raise
EARNINGS | Jul 16, 2026, 11:40 AM UTC
L
Abbott sees Q3 adjusted EPS $1.38-$1.46, consensus $1.42
Abbott sees Q3 adjusted EPS $1.38-$1.46, consensus $1.42
EQUITY | Jul 16, 2026, 11:34 AM UTC
L
Abbott raises FY26 adjusted EPS view to $5.45-$5.60 from $5.38-$5.58
FY26 consensus $5.48....
EQUITY | Jul 16, 2026, 11:33 AM UTC
L
Abbott reports Q2 adjusted EPS $1.31, consensus $1.28
Reports Q2 revenue...
EARNINGS | Jul 16, 2026, 11:32 AM UTC
H
Abbott Laboratories Raises FY2026 Adj EPS Guidance from $5.38-$5.58 to $5.45-$5.60 vs $5.49 Est
Abbott Laboratories (NYSE: ABT ) raises FY2026 Adj EPS guidance from $5.38-$5.58 to $5.45-$5.60 vs $5.49 analyst estimate..
EARNINGS | Jul 16, 2026, 11:31 AM UTC
H
ABT Abbott RESULTS: Q2, Q2 ADJ EPS $1.31 vs EST $1.28, Q2 sales $12.6B vs EST $12.50B, Abbott Earnings Notes:, Outlook FY sales growth 6.5%
ABT Abbott RESULTS: Q2, Q2 ADJ EPS $1.31 vs EST $1.28, Q2 sales $12.6B vs EST $12.50B, Abbott Earnings Notes:, Outlook FY sales growth 6.5% to 7.5%, Outlook FY ADJ EPS $5.45 to $5.60 vs EST $5.49, Abbott Laboratories (AB
RATES | Jul 16, 2026, 11:30 AM UTC
H
Earnings Calendar: • Earnings Before the Open: ABT CBSH CFG GE IIIN MAN PLD STT UNH USB WIT • Earnings After the Close: AA FNB INDB ISRG NFL
Earnings Calendar: • Earnings Before the Open: ABT CBSH CFG GE IIIN MAN PLD STT UNH USB WIT • Earnings After the Close: AA FNB INDB ISRG NFLX SFNC
EARNINGS | Jul 16, 2026, 11:03 AM UTC
H
Dow Jumps 150 Points Following Producer Inflation Data: Investor Sentiment Improves, Fear & Greed Index In ‘Neutral’ Zone
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the “Neutral” zone on Wednesday. U.S. stocks settled higher on Wednesday, with the Dow Jones index g
MACRO | Jul 16, 2026, 07:17 AM UTC
H
Netflix's Q3 Earnings Report Could Lead to $21.5 Billion Swing in Market Value
Earnings are in focus on Thursday, with a -selected slate that runs from industrial engines and logistics real estate to streaming and medical devices. With guidance and segment commentary often moving stocks as much as
EARNINGS | Jul 15, 2026, 07:31 PM UTC
L
Implied EPS movers for tomorrow AM: TSM +/-4.1%, UNH +/-5.1%, GE +/-4.3%, ABT +/-4.3%, PLD +/-2.7%, USB +/-2.8%, STT +/-3.5%, CFG +/-3.9%, C
Implied EPS movers for tomorrow AM: TSM +/-4.1%, UNH +/-5.1%, GE +/-4.3%, ABT +/-4.3%, PLD +/-2.7%, USB +/-2.8%, STT +/-3.5%, CFG +/-3.9%, CBSH +/-5.7%, MAN +/-7.8%, IIIN +/-7.5%
EARNINGS | Jul 15, 2026, 06:17 PM UTC
L
FDA Approves Abbott HIV Combo Next Assay Under 510(k) BK261345 On June 29, 2026
FDA Approves Abbott HIV Combo Next Assay Under 510(k) BK261345 On June 29, 2026
REGULATION | Jul 01, 2026, 05:28 PM UTC
L
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst Dav
EQUITY | Jul 01, 2026, 11:02 AM UTC
L
Baird Initiates Coverage On Abbott Laboratories with Outperform Rating, Announces Price Target of $121
Baird analyst David Rescott initiates coverage on Abbott Laboratories (NYSE: ABT ) with a Outperform rating and announces Price Target of $121.
EQUITY | Jul 01, 2026, 08:35 AM UTC
M
'The Baby Formula Probe Produced a Pile of Evidence. Then the DOJ Dropped the Case' - WSJ
DOJ drops baby formula probe case.
EQUITY | Jun 29, 2026, 06:54 AM UTC